Nanjing Vazyme Biotech Co., Ltd (SHA:688105)
China
· Delayed Price · Currency is CNY 19.90
+0.19 (0.96%)
Apr 29, 2026, 3:00 PM CST
Nanjing Vazyme Biotech Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 905.53 | 804.9 | 434.25 | 1,967 | 1,545 | 1,478 | Upgrade
|
| Trading Asset Securities | 2,035 | 2,049 | 2,222 | 1,514 | 1,719 | 1,976 | Upgrade
|
| Cash & Short-Term Investments | 2,940 | 2,854 | 2,656 | 3,481 | 3,264 | 3,454 | Upgrade
|
| Cash Growth | 1.17% | 7.45% | -23.69% | 6.65% | -5.49% | 239.50% | Upgrade
|
| Accounts Receivable | 471.63 | 460.05 | 483.61 | 351.93 | 839.62 | 322.32 | Upgrade
|
| Other Receivables | 9.91 | 9.65 | 20.81 | 4.07 | 7.72 | 4.67 | Upgrade
|
| Receivables | 481.54 | 469.7 | 504.42 | 356.01 | 847.35 | 326.99 | Upgrade
|
| Inventory | 351.52 | 343.67 | 362.18 | 346.25 | 364.2 | 242.19 | Upgrade
|
| Prepaid Expenses | - | - | 0.05 | - | - | - | Upgrade
|
| Other Current Assets | 40.91 | 40.18 | 48.58 | 47.12 | 89.71 | 28.1 | Upgrade
|
| Total Current Assets | 3,814 | 3,708 | 3,571 | 4,230 | 4,565 | 4,051 | Upgrade
|
| Property, Plant & Equipment | 599.91 | 617.48 | 726.07 | 767.3 | 679.48 | 308.98 | Upgrade
|
| Long-Term Investments | 75.86 | 79.96 | 54.83 | 47.3 | 22.31 | 18.48 | Upgrade
|
| Goodwill | 130.49 | 130.49 | 130.49 | 130.49 | 130.49 | - | Upgrade
|
| Other Intangible Assets | 83.53 | 86.63 | 95.19 | 101.24 | 49.7 | 16.65 | Upgrade
|
| Long-Term Accounts Receivable | - | - | 0.15 | - | - | - | Upgrade
|
| Long-Term Deferred Tax Assets | 174.12 | 166.62 | 146.04 | 106.51 | 67.12 | 24.87 | Upgrade
|
| Long-Term Deferred Charges | 207.55 | 220.12 | 278.91 | 280.54 | 318.31 | 145 | Upgrade
|
| Other Long-Term Assets | 15.4 | 19.06 | 45.51 | 82.53 | 172.69 | 42.25 | Upgrade
|
| Total Assets | 5,101 | 5,028 | 5,049 | 5,746 | 6,005 | 4,607 | Upgrade
|
| Accounts Payable | 75.16 | 91.59 | 90.4 | 146.82 | 318.78 | 118.76 | Upgrade
|
| Accrued Expenses | 61.41 | 116.69 | 129.74 | 112.52 | 258.07 | 104.7 | Upgrade
|
| Short-Term Debt | 858.43 | 686.68 | 551.32 | 1,134 | 272.21 | - | Upgrade
|
| Current Portion of Long-Term Debt | 35.5 | 28.43 | - | - | - | - | Upgrade
|
| Current Portion of Leases | - | - | 57.03 | 46.16 | 58.25 | 31.25 | Upgrade
|
| Current Income Taxes Payable | 23.53 | 32.86 | 0.6 | 0.03 | 0.54 | 20.02 | Upgrade
|
| Current Unearned Revenue | 58.73 | 72.14 | 54.87 | 55.92 | 214.55 | 95.03 | Upgrade
|
| Other Current Liabilities | 13.01 | 13.46 | 19.36 | 24.09 | 31.67 | 17.5 | Upgrade
|
| Total Current Liabilities | 1,126 | 1,042 | 903.33 | 1,520 | 1,154 | 387.26 | Upgrade
|
| Long-Term Leases | 113.57 | 127.33 | 143.36 | 106.89 | 127.68 | 59.93 | Upgrade
|
| Long-Term Unearned Revenue | 63.25 | 61.76 | 48.38 | 21.38 | 19.25 | 16.24 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.98 | 1.03 | 1.26 | 1.51 | 11.19 | 0.87 | Upgrade
|
| Other Long-Term Liabilities | 4.66 | 4.75 | 8.72 | 67.6 | 80.92 | 15.52 | Upgrade
|
| Total Liabilities | 1,308 | 1,237 | 1,105 | 1,717 | 1,393 | 479.83 | Upgrade
|
| Common Stock | 397.73 | 397.73 | 402.13 | 400.01 | 400.01 | 400.01 | Upgrade
|
| Additional Paid-In Capital | 2,341 | 2,339 | 2,512 | 2,442 | 2,429 | 2,422 | Upgrade
|
| Retained Earnings | 1,067 | 1,063 | 1,139 | 1,209 | 1,780 | 1,305 | Upgrade
|
| Treasury Stock | -5.01 | -3 | -104.4 | -20.01 | - | - | Upgrade
|
| Comprehensive Income & Other | -0.55 | -0.63 | -3.97 | -1.72 | - | - | Upgrade
|
| Total Common Equity | 3,800 | 3,796 | 3,945 | 4,029 | 4,609 | 4,127 | Upgrade
|
| Minority Interest | -7.08 | -4.82 | -1.63 | -0.11 | 3.2 | - | Upgrade
|
| Shareholders' Equity | 3,793 | 3,791 | 3,944 | 4,029 | 4,612 | 4,127 | Upgrade
|
| Total Liabilities & Equity | 5,101 | 5,028 | 5,049 | 5,746 | 6,005 | 4,607 | Upgrade
|
| Total Debt | 1,007 | 842.44 | 751.71 | 1,287 | 458.14 | 91.18 | Upgrade
|
| Net Cash (Debt) | 1,933 | 2,012 | 1,905 | 2,194 | 2,806 | 3,362 | Upgrade
|
| Net Cash Growth | 6.39% | 5.62% | -13.19% | -21.81% | -16.56% | 230.91% | Upgrade
|
| Net Cash Per Share | 4.55 | 4.84 | 5.26 | 5.57 | 7.03 | 9.27 | Upgrade
|
| Filing Date Shares Outstanding | 418.17 | 669.06 | 397.82 | 397 | 400.01 | 400.01 | Upgrade
|
| Total Common Shares Outstanding | 418.17 | 669.06 | 397.82 | 397 | 400.01 | 400.01 | Upgrade
|
| Working Capital | 2,688 | 2,666 | 2,668 | 2,711 | 3,411 | 3,664 | Upgrade
|
| Book Value Per Share | 9.09 | 5.67 | 9.92 | 10.15 | 11.52 | 10.32 | Upgrade
|
| Tangible Book Value | 3,586 | 3,579 | 3,720 | 3,798 | 4,429 | 4,111 | Upgrade
|
| Tangible Book Value Per Share | 8.57 | 5.35 | 9.35 | 9.57 | 11.07 | 10.28 | Upgrade
|
| Machinery | - | - | 712.88 | 656.11 | 513.97 | 250.31 | Upgrade
|
| Construction In Progress | - | - | 69.42 | 127.48 | 69.44 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.